Labroots Cancer Research

Explore how automation + informatics are streamlining oncology sequencing & reporting—from sample to insight at @illumina’s latest virtual event. Launching May 19: buff.ly/Z3YlVs3 #informatics #oncologyresearch #cancer #precisionmedicine

Researchers discover novel biomarker that can predict therapeutic efficacy in patients with colorectal cancer. buff.ly/1CxW1xQ

Discover the power of QCI Precision Insights, a professional clinical variant interpretation service for molecular oncology. Join our on-demand webinar and learn how this solution delivers real-world clinical impact. Register: buff.ly/H8H5cEm @QIAGENBiox

Scientists discover how inhibiting a surface protein on immune cells can elicit robust anti-tumor effects and improve pancreatic cancer treatment. buff.ly/50rXna0

🧪 Discover the latest research driving innovation in cancer immunotherapy. Join our live poster hall at the Immuno-Oncology Virtual Event Series and connect with experts through interactive chat and discussion. Sign up now👉 buff.ly/7E6v8AU #LRimmuno #immunooncology

Soils and sediments act as long-term PFAS reservoirs, influencing environmental exposure long after release. Learn how passive samplers can improve PFAS monitoring and environmental risk assessment. Download the eBook now! buff.ly/wijnpmn

Popular weight loss drugs targeting GLP-1 pathways could help prevent colorectal cancer. buff.ly/5muVMXf

Robert‑Debré Hospital boosts rare disease research with an automated Agilent NGS workflow, streamlining prep, enrichment & QC. A unified setup now processes 5,000+ samples/year with higher accuracy and efficiency. Download the case study to learn more. buff.ly/xrG656n

👩‍🔬 Join us at AACR 2026 to see how @Elabscience_bio can empower your 𝐜𝐚𝐧𝐜𝐞𝐫 👉 Learn more: buff.ly/VuuvSSn #CancerResearch #AACR #Immunology #CellBiology

Knowledge is our best weapon. 🛡️ Join the official Labroots Cancer Research community on Bluesky for the latest breakthroughs in oncology, immunotherapy, and the science bringing us closer to a cure. 🔗 buff.ly/GSY5h3e

Researchers discover that natural, high binding affinity antibodies contribute to anaphylaxis. buff.ly/BIVfL7h

Many breast cancer survivors also have high blood pressure. A new study shows that the drugs used to manage blood pressure impact how long these patients live. buff.ly/B3SSQqe

Scientists develop a novel approach to analyze cell profiles, which can lead to improved drug development and patient outcomes. buff.ly/vjVqW5E

In oncology care, every diagnostic decision matters. Discover how integrated molecular workflows can streamline respiratory testing, reduce turnaround times, and support confident clinical decisions—when patients need answers most. buff.ly/PzpHj4O

The development of monoclonal antibodies has paved the way for innovative treatments in oncology. In this whitepaper, we explore the progress in mAbs development and share insights into how automation can expedite the journey from bench to bedside. buff.ly/4aNQ1hN

On April 14, discover how NGS is transforming MRD detection in AML. Compare NGS vs traditional methods + gain insights into relapse prediction. @OxfordGeneTech Register today! buff.ly/1XnTBmV

A comprehensive review of literature published between 2017 and 2025 indicates a link between cancer and vaping. buff.ly/85LKaw1

Robert‑Debré Hospital boosts rare disease research with an automated Agilent NGS workflow, streamlining prep, enrichment & QC. A unified setup now processes 5,000+ samples/year with higher accuracy and efficiency. Download the case study to learn more. buff.ly/Sw6lrOx

Researchers develop novel way to deliver engineered immunotherapy to patients with pancreatic cancer. buff.ly/rlepLip

PFAS doesn't disappear. Soils and sediments act as long-term PFAS reservoirs, influencing environmental exposure long after release. Learn how passive samplers can improve PFAS monitoring and environmental risk assessment. Download the eBook now! buff.ly/dNrBc7K